Kipspharma Signs Exclusive Domestic Distributorship Deal with Illuco, Expanding into Medical Devices View original image

Kips Biopharma (hereafter Kipspharma) is joining hands with global small-but-strong optical medical device company Illuco to target the medical device market.


Kipspharma announced on the 6th that it has signed an exclusive domestic distributorship agreement with Illuco for Class I medical devices, including medical loupes (loupe) and cameras, as well as examination lights. Under this agreement, Kipspharma will exclusively supply Illuco's premium medical device lineup to the Korean market.


This contract is expected to serve as an important momentum for Kipspharma to expand its business domain from pharmaceuticals to medical devices. The markets it is entering, such as loupes, cameras, and lighting devices, are high-growth segments that have been recording robust annual growth rates in the 10% range.


Partner company Illuco is globally recognized in the fields of optical design and precision machining. It supplies key optical components to global companies such as Nvidia and Meta in the United States, exports products to more than 50 countries worldwide, and has overseas distributors in 30 countries, making it a global small-but-strong enterprise. It became the first Asian loupe company to win the Red Dot Design Award in 2022, and has since been recognized for its technology and design by winning the IDEA Design Award in 2024, the Export Tower Award, and being selected in 2025 for the Global Small but Strong Enterprise 1000+ program.


Its flagship product, the Angled Loupe, is an ergonomic device designed so that medical staff can look straight ahead and perform examinations and surgeries without bending their necks. It dramatically reduces neck and back fatigue during long surgeries and is therefore highly favored by physicians. In addition, the company supplies wired and wireless light systems that provide a clear field of view, as well as educational cameras capable of transmitting and recording surgical scenes in real time.


Kipspharma plans to fully leverage its existing sales network with hospitals and clinics, along with its marketing capabilities, to expand distribution channels across various specialties including surgery, dentistry, and veterinary medicine. In particular, it intends to participate in major domestic academic conferences and exhibitions scheduled for the first half of 2026 to showcase the excellence of its products and rapidly raise brand awareness.



Kim Hayong, CEO of Kipspharma, said, "I am confident that the combination of Illuco's innovative optical technology and Kipspharma's solid distribution network will create powerful synergy," adding, "Starting with this exclusive agreement, we will diversify our medical business portfolio and provide differentiated, consumer-centered services to take the lead in the domestic medical device market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing